ArticlePharmacoEconomics - open2020

Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention.

Itziar Oyagüez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.